Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Stem Cells in Drug Discovery

Davide Danovi's Biography

Davide Danovi, Director, Cell Phenotyping Platform, Kings College London

Davide Danovi holds an MD from University of Milan and a PhD in Molecular Oncology from the European Institute of Oncology where he demonstrated the causative role of the HdmX protein in human cancer. He completed his postdoctoral training working with Prof. Austin Smith and Dr. Steve Pollard at the University of Cambridge and at University College London where he developed a screening platform to isolate compounds active on human neural stem cells from normal or brain tumour samples. Prior to his current role, he worked as principal scientist at a novel biotechnology company founded to isolate drugs for regenerative medicine using innovative stem cell technologies.

Davide Danovi Image

Collaborative Phenotyping at King’s College London: Hipsci and the Stem Cell Hotel

Monday, 6 March 2017 at 11:45

Add to Calendar ▼2017-03-06 11:45:002017-03-06 12:45:00Europe/LondonCollaborative Phenotyping at King’s College London: Hipsci and the Stem Cell

- Using relevant cells for high content analysis
- HipSci: diverse constituents in genomics, proteomics, cell biology and clinical genetics for a national iPS cell resource to carry out cellular genetic studies.
- The Stem Cell Hotel: building a dedicated space for collaborative phenotyping within the premises of the Centre for Stem Cells & Regenerative Medicine at KCL.

Add to Calendar ▼2017-03-06 00:00:002017-03-07 00:00:00Europe/LondonStem Cells in Drug